Обследование и диагностика (сестринское дело)
11 статей · 2 журналов
Журналы подкатегории (2)
- Communications Medicine · Springer Nature (11)
- Nursing · Springer Nature (0)
-
Metabolic and gut microbiome responses to personalized nutrition during metformin therapy in prediabetes and early‑stage type 2 diabetes: a randomized clinical trial
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02009-3 People with type 2 diabetes can have too much sugar in their blood stream, which can lead to health problems. Metformin is a common medication...
-
NSUN4 promotes the growth and metastasis of intrahepatic cholangiocarcinoma by modulating mitochondrial translation and respiratory-chain function
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02013-7 The authors identify the mitochondrial RNA methyltransferase, NSUN4 as a potential therapeutic target in intrahepatic cholangiocarcinoma, with...
-
Patient-derived organoids reveal strain-specific efficacy of engineered bacteria in colorectal cancer
Communications Medicine, Published online: 18 November 2026; doi:10.1038/s43856-026-01992-x ED Summary: O’Connor et al. use a patient-derived organoid co-culture platform to evaluate engineered bacterial therapies for colorectal cancer...
-
Macrophage Slfn4 attenuates colonic inflammation and tumorigenesis through Rac1-dependent phagocytosis and oxidative burst
Communications Medicine, Published online: 17 November 2026; doi:10.1038/s43856-026-02012-8 Macrophage Slfn4 attenuates colonic inflammation and tumorigenesis through Rac1-dependent phagocytosis and oxidative burst
-
The health and economic impact of COVID-19 vaccine misinformation in Canada
Communications Medicine, Published online: 16 November 2026; doi:10.1038/s43856-026-01727-y Ozawa et al. simulated the impact of misinformation in Canada on individuals delaying and refusing vaccination during the COVID-19 pandemic....
-
Trait absorption association with ketamine’s benefits and drug-context interactions in treatment-resistant depression: exploratory results from the MUSIK randomized clinical trial
Communications Medicine, Published online: 14 November 2026; doi:10.1038/s43856-026-01987-8 Garel et al. explore the influence of the personality trait absorption in the MUSIK trial which administered 181 doses of ketamine, with either...
-
Contextualizing biological heterogeneity in brain structural normativity assessments across the aging continuum with the nearest neighbor normativity framework
Communications Medicine, Published online: 13 November 2026; doi:10.1038/s43856-026-01903-0 Leenings et al. methodologically reformulate neuroimaging standards to explicitly account for natural inter-individual variability of brain...
-
Analyses of plasma protein levels in relation to body composition in the UK Biobank
Communications Medicine, Published online: 13 November 2026; doi:10.1038/s43856-026-01964-1 Orešković et al. use UK Biobank proteomic and body composition data, applying machine learning, cis Mendelian randomisation, and colocalisation...
-
Development and validation of a machine learning model to predict the daily risk of febrile neutropenia in patients with AML undergoing chemotherapy
Communications Medicine, Published online: 13 November 2026; doi:10.1038/s43856-026-02001-x Development and validation of a machine learning model to predict the daily risk of febrile neutropenia in patients with AML undergoing chemotherapy
-
Dysfunction of hepatic lipid metabolism in mice haploinsufficient for the histone methyltransferase Kmt2c
Communications Medicine, Published online: 11 November 2026; doi:10.1038/s43856-026-01971-2 Dysfunction of hepatic lipid metabolism in mice haploinsufficient for the histone methyltransferase Kmt2c
-
Comparing malaria transmission blocking efficacy of Primaquine and Tafenoquine with in vivo pre-clinical models
Communications Medicine, Published online: 10 November 2026; doi:10.1038/s43856-026-01977-w Duffey, Zakutansky, et al compare the transmission-blocking activity and drug exposure of primaquine and tafenoquine in two preclinical malaria...